Research Options:
Week of Expected Pricing Pending
Company Name Kinemed Inc
Proposed Ticker KNMD
CUSIP 49459P107
Business Description A revenue-generating health technology company that has developed a proprietary biomarker platform technology with numerous applications in drug development and medical diagnostics.
Lead Underwriter Feltl and Company
Co-Managers Laidlaw & Company (UK) Ltd , MLV & Co. LLC
Initial Shares 4,500,000
Revised Initial Shares N/A
Initial Price $6.50-$7.50
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.